Neostigmine - subcutaneous administration for acute colonic pseudo-obstruction

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Mon, 08/26/2019 - 09:56
#1
Matthew T. Beaulac
Matthew T. Beaulac's picture
Offline
Last seen: 1 month 3 weeks ago
Joined: 09/02/2016 - 08:20
Neostigmine - subcutaneous administration for acute colonic pseudo-obstruction

Hello,

I'm interested in obtaining information about other hospitals that use neostigmine subcutaneously for the indication of acute colonic pseudo--obstruction.

What administration instructions/monitoring parameters are utilized at your facility.

Thank you,

Matthew Beaulac, PharmD, MS

Tags: 

Top